IL6 and alkaline phosphatase measurement: The important role of leukocyte activation and IL-1β release in development and course of AP has been additionally evidenced by observation that administration of IL-1 receptor antagonist prevents a serum rise in IL-6 and TNF-α, and decreases the severity of AP [31].